REPLIGEN CORP Liabilities, Noncurrent
REPLIGEN CORP (RGEN) had Liabilities, Noncurrent of $707.74 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-02-26
- 2025-12-31: Liabilities, Noncurrent $707.74M.
- 2025-09-30: Liabilities, Noncurrent $709.49M.
- 2025-06-30: Liabilities, Noncurrent $716.87M.
- 2025-03-31: Liabilities, Noncurrent $714.66M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $707.74M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $709.49M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $716.87M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $714.66M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $730.16M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $705.59M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $706.76M 10-Q/A · filed 2024-11-18 | $701.25M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $706.55M 10-Q/A · filed 2024-11-18 | $700.35M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $701.40M 10-K · filed 2025-03-14 | $695.05M 10-K · filed 2024-02-22 |
| 2023-09-30 | $170.05M 10-Q/A · filed 2024-11-18 | $162.21M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $211.85M 10-Q/A · filed 2024-11-18 | $204.49M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $204.67M 10-Q/A · filed 2024-11-18 | $192.42M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $216.70M 10-Q/A · filed 2024-11-18 | $209.76M 10-K · filed 2023-02-22 |
| 2022-09-30 | $216.73M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $216.03M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $193.09M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $233.03M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $176.69M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $80.55M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $57.78M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $54.78M 10-K · filed 2022-02-17 | |
| 2011-09-30 | $580.33K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $576.53K 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $584.16K 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |